Australia markets closed

Bellevue Life Sciences Acquisition Corp. (BLACU)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
10.860.00 (0.00%)
At close: 04:00PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
15.419
124.501
4.757
62.653
Total cash
15.419
124.501
4.757
62.653
Total current assets
22.627
124.501
4.757
62.653
Non-current assets
Other long-term assets
36,605
-
-
-
Total non-current assets
36,605
1,101
700.33
260.096
Total assets
36,628
1,226
705.087
322.749
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
-
1,200
400
300
Accounts payable
1,082
34
2.847
0
Taxes payable
524.562
0
-
-
Accrued liabilities
0
12.362
294.36
21.561
Total current liabilities
2,038
1,263
707.207
321.561
Non-current liabilities
Total non-current liabilities
2,070
0
0
0
Total liabilities
4,108
1,263
707.207
321.561
Stockholders' equity
Common stock
36,426
0.173
0.173
0.173
Retained earnings
-3,907
-62.508
-27.12
-23.812
Total stockholders' equity
32,519
-37.508
-2.12
1.188
Total liabilities and stockholders' equity
36,628
1,226
705.087
322.749